ESTRADIOL AND LEVONORGESTREL

ESTRADIOL AND LEVONORGESTREL was reported 2062 times

ESTRADIOL AND LEVONORGESTREL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NON-HODGKIN'S LYMPHOMA STAGE I 1 0.1000
1 THELITIS 1 0.0833
2 DEVICE EFFECT VARIABLE 1 0.0556
3 MEDICAL DEVICE SITE RASH 2 0.0526
4 PRODUCT DIFFICULT TO REMOVE 3 0.0500
5 RICKETTSIOSIS 1 0.0455
6 DEVICE USED FOR UNAPPROVED SCHEDULE 1 0.0345
7 PRODUCT SHAPE ISSUE 29 0.0307
8 ANISOMASTIA 1 0.0294
9 PATIENT DISSATISFACTION WITH DEVICE 6 0.0238
10 PHOTOSENSITIVITY ALLERGIC REACTION 1 0.0213
11 POSTMENOPAUSAL HAEMORRHAGE 55 0.0211
12 PRODUCT ADHESION ISSUE 668 0.0187
13 DEVICE ADHESION ISSUE 268 0.0175
14 PRODUCT PHYSICAL ISSUE 348 0.0172
15 LIPOMA OF BREAST 1 0.0169
16 ENDOLYMPHATIC HYDROPS 1 0.0159
17 MEDICAL DEVICE SITE DRYNESS 1 0.0154
18 MISOPHONIA 1 0.0147
19 DERMAL ABSORPTION IMPAIRED 4 0.0143
20 APPLICATION SITE RASH 194 0.0141
21 TEMPERATURE DIFFERENCE OF EXTREMITIES 1 0.0141
22 MENOPAUSAL SYMPTOMS 32 0.0137
23 APPLICATION SITE HYPERSENSITIVITY 16 0.0132
24 UTERINE HAEMORRHAGE 56 0.0131
25 DEVICE MATERIAL ISSUE 24 0.0114
26 APPLICATION SITE FISSURE 1 0.0111
27 OFF LABEL USE OF DEVICE 14 0.0103
28 WITHDRAWAL BLEED 7 0.0096
29 APPLICATION SITE URTICARIA 21 0.0093
30 POST POLIO SYNDROME 1 0.0089
31 REPETITIVE STRAIN INJURY 1 0.0088
32 APPLICATION SITE ULCER 6 0.0085
33 APPLICATION SITE BLEEDING 2 0.0081
34 APPLICATION SITE INFECTION 4 0.0079
35 MEDICAL DEVICE SITE ERYTHEMA 1 0.0078
36 APPLICATION SITE IRRITATION 94 0.0075
37 ELECTROCARDIOGRAM QT INTERVAL 1 0.0069
38 ENDOMETRIAL ATROPHY 1 0.0069
39 APPLICATION SITE ODOUR 1 0.0069
40 CONTACT LENS INTOLERANCE 1 0.0064
41 ADENOCARCINOMA OF THE CERVIX 1 0.0062
42 APPLICATION SITE WOUND 1 0.0061
43 MENIERE'S DISEASE 2 0.0058
44 APPLICATION SITE PERSPIRATION 1 0.0058
45 BLOOD OESTROGEN DECREASED 4 0.0057
46 INCORRECT DOSE ADMINISTERED BY PRODUCT 9 0.0056
47 APPLICATION SITE PUSTULES 2 0.0055
48 ADMINISTRATION SITE DISCOMFORT 1 0.0053
49 CERVICAL POLYP 2 0.0053
50 APPLICATION SITE INJURY 1 0.0053
51 SICCA SYNDROME 1 0.0052
52 SALPINGO-OOPHORECTOMY BILATERAL 1 0.0050
53 APPLICATION SITE PRURITUS 110 0.0048
54 APPLICATION SITE REACTION 32 0.0045
55 PATIENT DISSATISFACTION WITH TREATMENT 8 0.0041
56 APPLICATION SITE DISCOMFORT 7 0.0039
57 APPLICATION SITE ERYTHEMA 102 0.0039
58 SUSPECTED PRODUCT QUALITY ISSUE 7 0.0038
59 BREAST TENDERNESS 27 0.0036
60 BREAST ENGORGEMENT 1 0.0034
61 SIMILAR REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0033
62 APPLICATION SITE SCAR 4 0.0032
63 ALLERGY TO ARTHROPOD BITE 1 0.0031
64 APPLICATION SITE EROSION 4 0.0031
65 NODAL OSTEOARTHRITIS 1 0.0031
66 HOT FLUSH 230 0.0030
67 PACKAGING DESIGN ISSUE 1 0.0030
68 ALLERGIC RESPIRATORY SYMPTOM 1 0.0030
69 METRORRHAGIA 51 0.0030
70 INFUSION SITE URTICARIA 2 0.0030
71 MASS EXCISION 1 0.0029
72 APPLICATION SITE HAEMORRHAGE 8 0.0029
73 OESOPHAGITIS ULCERATIVE 2 0.0029
74 PREMENSTRUAL SYNDROME 4 0.0029
75 HORMONE LEVEL ABNORMAL 14 0.0029
76 ANDROGEN DEFICIENCY 1 0.0028
77 APPLICATION SITE VESICLES 18 0.0028
78 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
79 OVARIAN MASS 2 0.0027
80 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
81 BREAST RECONSTRUCTION 1 0.0027
82 INTERMENSTRUAL BLEEDING 14 0.0025
83 MEDICAL DEVICE SITE DISCOMFORT 2 0.0025
84 DEVICE COLOUR ISSUE 1 0.0025
85 LICHENIFICATION 1 0.0024
86 DRUG WITHDRAWAL HEADACHE 1 0.0024
87 APPLICATION SITE LACERATION 1 0.0024
88 GENITAL HAEMORRHAGE 31 0.0024
89 SWEAT GLAND DISORDER 1 0.0024
90 DEVICE BREAKAGE 94 0.0023
91 POLYMENORRHOEA 8 0.0023
92 PRODUCT PACKAGING DIFFICULT TO OPEN 6 0.0023
93 MANUFACTURING ISSUE 1 0.0022
94 APPLICATION SITE DERMATITIS 2 0.0021
95 INTERVERTEBRAL DISC INJURY 1 0.0021
96 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
97 PRODUCT CLOSURE REMOVAL DIFFICULT 2 0.0020
98 UTERINE CERVIX STENOSIS 1 0.0019
99 DEVICE INEFFECTIVE 2 0.0019
100 BREAST SWELLING 5 0.0019
101 APPLICATION SITE BURN 9 0.0018
102 DEVICE USE ISSUE 31 0.0018
103 TRICHOTILLOMANIA 1 0.0017
104 HYPOAESTHESIA EYE 1 0.0017
105 ADENOMYOSIS 1 0.0017
106 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
107 VAGINAL HAEMORRHAGE 73 0.0017
108 DEVICE DEFECTIVE 29 0.0017
109 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
110 BLADDER PROLAPSE 2 0.0016
111 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 76 0.0016
112 BLADDER DISCOMFORT 2 0.0016
113 NIPPLE PAIN 3 0.0015
114 APPLICATION SITE INFLAMMATION 2 0.0014
115 APPLICATION SITE PAIN 31 0.0014
116 BREAST PAIN 15 0.0014
117 APPLICATION SITE SWELLING 7 0.0014
118 POOR QUALITY DRUG ADMINISTERED 9 0.0014
119 APPLICATION SITE SCAB 3 0.0014
120 ATROPHIC VULVOVAGINITIS 1 0.0014
121 FIBROCYSTIC BREAST DISEASE 1 0.0014
122 NIGHT SWEATS 43 0.0013
123 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 265 0.0013
124 UTERINE ENLARGEMENT 1 0.0013
125 DEVICE DAMAGE 1 0.0013
126 HEPATITIS VIRAL 1 0.0012
127 FRUSTRATION TOLERANCE DECREASED 10 0.0012
128 ENDOMETRIAL HYPERPLASIA 1 0.0012
129 APPLICATION SITE DISCOLOURATION 5 0.0012
130 APPLICATION SITE DRYNESS 4 0.0012
131 SKIN WOUND 2 0.0012
132 INTENTIONAL DEVICE USE ISSUE 1 0.0012
133 TONGUE PRURITUS 1 0.0012
134 PRODUCT PACKAGING ISSUE 11 0.0012
135 UTERINE DILATION AND CURETTAGE 1 0.0011
136 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
137 UTERINE SPASM 2 0.0011
138 GASTRIC OPERATION 1 0.0011
139 FIBROMA 1 0.0011
140 ABNORMAL WITHDRAWAL BLEEDING 1 0.0011
141 BIOPSY 1 0.0011
142 PROGESTERONE RECEPTOR ASSAY POSITIVE 1 0.0011
143 BUNDLE BRANCH BLOCK 1 0.0011
144 OVARIAN DISORDER 1 0.0011
145 THERAPEUTIC RESPONSE INCREASED 1 0.0011
146 VAGINAL DISORDER 1 0.0010
147 MOTION SICKNESS 2 0.0010
148 APPLICATION SITE BRUISE 1 0.0010
149 PRODUCT QUALITY ISSUE 139 0.0010
150 PRODUCT PRESCRIBING ISSUE 22 0.0010
151 ONYCHALGIA 1 0.0010
152 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
153 PRODUCT COATING ISSUE 1 0.0010
154 APPLICATION SITE EXFOLIATION 4 0.0010
155 BREAST DISCOMFORT 1 0.0010
156 WAIST CIRCUMFERENCE INCREASED 1 0.0010
157 PRODUCT BLISTER PACKAGING ISSUE 1 0.0010
158 PRE-EXISTING CONDITION IMPROVED 6 0.0010
159 SINUSITIS BACTERIAL 1 0.0009
160 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
161 EAR SWELLING 2 0.0009
162 JOINT CONTRACTURE 1 0.0009
163 BREAST ENLARGEMENT 3 0.0009
164 EPSTEIN-BARR VIRAEMIA 1 0.0009
165 MULTIPLE USE OF SINGLE-USE PRODUCT 5 0.0009
166 OESTROGEN RECEPTOR ASSAY POSITIVE 1 0.0009
167 PRODUCT AVAILABILITY ISSUE 20 0.0009
168 APPLICATION SITE DISCHARGE 1 0.0009
169 UTERINE DISORDER 2 0.0009
170 RECTAL ULCER 1 0.0009
171 INCISION SITE PAIN 1 0.0009
172 MENSTRUAL DISORDER 7 0.0008
173 LABILE BLOOD PRESSURE 1 0.0008
174 PRODUCT SUPPLY ISSUE 6 0.0008
175 INCORRECT DOSAGE ADMINISTERED 4 0.0008
176 NASAL PRURITUS 1 0.0008
177 DERMATITIS CONTACT 9 0.0008
178 APPLICATION SITE WARMTH 1 0.0008
179 ADNEXA UTERI PAIN 1 0.0008
180 PRODUCT COLOUR ISSUE 4 0.0008
181 MENOPAUSE 2 0.0008
182 NON-HODGKIN'S LYMPHOMA 1 0.0008
183 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
184 CYSTITIS NONINFECTIVE 1 0.0007
185 SKIN WRINKLING 2 0.0007
186 HYPOMENORRHOEA 2 0.0007
187 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
188 CATAPLEXY 1 0.0007
189 PRECANCEROUS CELLS PRESENT 1 0.0007
190 PREGNANCY ON CONTRACEPTIVE 1 0.0007
191 ABDOMINAL PAIN LOWER 17 0.0007
192 SKIN STRIAE 1 0.0007
193 MEDICAL DEVICE DISCOMFORT 2 0.0007
194 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
195 RUBBER SENSITIVITY 1 0.0007
196 PRODUCT DEPOSIT 1 0.0006
197 VULVOVAGINAL DRYNESS 2 0.0006
198 COSTOCHONDRITIS 1 0.0006
199 EXPIRED DEVICE USED 2 0.0006
200 GASTRIC DILATATION 1 0.0006
201 NEUROPATHY 1 0.0006
202 MASTECTOMY 1 0.0006
203 BREAST DISCHARGE 1 0.0006
204 INFUSION SITE DISCHARGE 1 0.0006
205 BURNS SECOND DEGREE 1 0.0006
206 FOOD INTERACTION 1 0.0006
207 MOOD SWINGS 18 0.0006
208 FEAR OF DISEASE 1 0.0006
209 UTERINE POLYP 1 0.0006
210 HYPERSEXUALITY 1 0.0005
211 OESOPHAGEAL SPASM 1 0.0005
212 MIDDLE INSOMNIA 10 0.0005
213 INCORRECT DRUG ADMINISTRATION DURATION 15 0.0005
214 DRUG DOSE OMISSION 87 0.0005
215 MENOMETRORRHAGIA 1 0.0005
216 AFFECT LABILITY 5 0.0005
217 PRODUCT LABEL CONFUSION 3 0.0005
218 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
219 SKIN ODOUR ABNORMAL 2 0.0005
220 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
221 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
222 INCORRECT DOSE ADMINISTERED BY DEVICE 13 0.0005
223 SKIN INDURATION 1 0.0005
224 MOOD ALTERED 13 0.0005
225 ORAL PRURITUS 1 0.0004
226 NECK SURGERY 1 0.0004
227 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
228 ORAL SURGERY 1 0.0004
229 SKIN ABRASION 2 0.0004
230 PANIC REACTION 3 0.0004
231 PRODUCT PACKAGING CONFUSION 1 0.0004
232 HAEMATOLOGICAL INFECTION 1 0.0004
233 VAGINAL DISCHARGE 4 0.0004
234 EXCORIATION 1 0.0004
235 HOSTILITY 1 0.0004
236 SKIN IRRITATION 18 0.0004
237 ABNORMAL UTERINE BLEEDING 1 0.0004
238 CATHETER SITE PAIN 1 0.0004
239 PERSONALITY DISORDER 1 0.0004
240 EXFOLIATIVE RASH 1 0.0004
241 ANIMAL BITE 1 0.0004
242 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
243 PRODUCT SIZE ISSUE 2 0.0004
244 POOR QUALITY SLEEP 8 0.0004
245 MIGRAINE WITH AURA 1 0.0004
246 TRICHORRHEXIS 1 0.0004
247 MENORRHAGIA 7 0.0004
248 DRUG TOLERANCE DECREASED 1 0.0004
249 SKIN REACTION 5 0.0004
250 HERPES VIRUS INFECTION 2 0.0003
251 HYPERTONIC BLADDER 1 0.0003
252 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
253 AMENORRHOEA 6 0.0003
254 HYPERHIDROSIS 44 0.0003
255 NECK INJURY 1 0.0003
256 URINE ODOUR ABNORMAL 2 0.0003
257 INFUSION SITE REACTION 1 0.0003
258 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
259 VULVOVAGINAL BURNING SENSATION 2 0.0003
260 PORTAL HYPERTENSION 1 0.0003
261 INFUSION SITE SWELLING 2 0.0003
262 DRUG EFFECT INCREASED 1 0.0003
263 ADVERSE EVENT 29 0.0003
264 SCREAMING 2 0.0003
265 SKIN EROSION 1 0.0003
266 CARDIAC FLUTTER 2 0.0003
267 INFUSION SITE HAEMORRHAGE 1 0.0003
268 PRODUCT USE ISSUE 57 0.0003
269 CRYING 11 0.0003
270 SKIN INJURY 1 0.0003
271 PEPTIC ULCER 1 0.0003
272 POOR QUALITY DEVICE USED 3 0.0003
273 PLANTAR FASCIITIS 1 0.0003
274 BREAST MASS 2 0.0003
275 MIGRAINE 28 0.0003
276 RASH ERYTHEMATOUS 14 0.0003
277 TACHYPHRENIA 1 0.0003
278 DEVICE USE ERROR 10 0.0003
279 THROMBOPHLEBITIS 1 0.0003
280 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
281 THERMAL BURN 2 0.0003
282 DEVICE PLACEMENT ISSUE 1 0.0003
283 RECTAL DISCHARGE 1 0.0003
284 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
285 BONE DENSITY ABNORMAL 1 0.0003
286 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
287 THROAT CLEARING 1 0.0003
288 EPIGASTRIC DISCOMFORT 1 0.0003
289 BRAIN FOG 4 0.0003
290 MULTIPLE ALLERGIES 2 0.0003
291 FUNGAL SKIN INFECTION 1 0.0002
292 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
293 HAIR DISORDER 2 0.0002
294 THYROID FUNCTION TEST ABNORMAL 1 0.0002
295 ABDOMINAL DISTENSION 25 0.0002
296 PRODUCT DISPENSING ISSUE 1 0.0002
297 PRODUCT CONTAINER ISSUE 2 0.0002
298 IRRITABILITY 14 0.0002
299 ABNORMAL SENSATION IN EYE 1 0.0002
300 TEARFULNESS 1 0.0002
301 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
302 OCULAR ICTERUS 1 0.0002
303 CHAPPED LIPS 1 0.0002
304 ADVERSE REACTION 3 0.0002
305 RASH PAPULAR 5 0.0002
306 IRON DEFICIENCY 1 0.0002
307 HEAVY MENSTRUAL BLEEDING 2 0.0002
308 URINARY TRACT DISORDER 1 0.0002
309 INSOMNIA 58 0.0002
310 SYNOVIAL CYST 1 0.0002
311 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
312 YELLOW SKIN 1 0.0002
313 SKIN TIGHTNESS 1 0.0002
314 ENDOMETRIOSIS 1 0.0002
315 APHAGIA 1 0.0002
316 MENTAL IMPAIRMENT 5 0.0002
317 EXPIRED DRUG ADMINISTERED 1 0.0002
318 ABDOMINAL TENDERNESS 1 0.0002
319 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
320 NO ADVERSE EVENT 36 0.0002
321 MEDICATION ERROR 11 0.0002
322 VULVOVAGINAL PRURITUS 1 0.0002
323 INCORRECT DOSE ADMINISTERED 45 0.0002
324 DERMATITIS 4 0.0002
325 PRODUCT USE COMPLAINT 3 0.0002
326 SCRATCH 2 0.0002
327 LEARNING DISABILITY 1 0.0002
328 FEELING ABNORMAL 45 0.0002
329 RASH PRURITIC 10 0.0002
330 DEAFNESS UNILATERAL 1 0.0002
331 FUNGAL INFECTION 6 0.0002
332 SKIN INFECTION 2 0.0002
333 PRODUCT LEAKAGE 1 0.0002
334 ANGER 6 0.0002
335 SCAR 3 0.0002
336 CHOLECYSTECTOMY 2 0.0002
337 VISUAL DISTURBANCE 1 0.0002
338 ENTEROCOLITIS 1 0.0002
339 SKIN WARM 1 0.0002
340 RASH MACULAR 6 0.0002
341 DEPRESSED MOOD 9 0.0002
342 COMPLICATION OF DEVICE REMOVAL 3 0.0002
343 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
344 UNDERDOSE 12 0.0002
345 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
346 PIGMENTATION DISORDER 1 0.0002
347 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
348 CYSTITIS 5 0.0002
349 PROCTALGIA 1 0.0002
350 INFUSION SITE PAIN 2 0.0002
351 BREAST CANCER STAGE III 1 0.0002
352 ALOPECIA 30 0.0002
353 BEDRIDDEN 2 0.0002
354 DYSMENORRHOEA 2 0.0002
355 SKIN DISORDER 5 0.0001
356 MENSTRUATION IRREGULAR 4 0.0001
357 WRONG PRODUCT ADMINISTERED 1 0.0001
358 PRODUCT LABEL ISSUE 1 0.0001
359 HAIR GROWTH ABNORMAL 1 0.0001
360 FORMICATION 1 0.0001
361 EXTRASYSTOLES 1 0.0001
362 WITHDRAWAL SYNDROME 6 0.0001
363 SLEEP DISORDER 10 0.0001
364 PRURITUS GENERALISED 3 0.0001
365 PARAESTHESIA ORAL 2 0.0001
366 TONGUE DISORDER 1 0.0001
367 PRODUCT DISPENSING ERROR 3 0.0001
368 DRUG EFFECT INCOMPLETE 5 0.0001
369 PANIC ATTACK 5 0.0001
370 UTERINE LEIOMYOMA 1 0.0001
371 SUNBURN 1 0.0001
372 DRUG DISPENSING ERROR 2 0.0001
373 FEELING HOT 8 0.0001
374 EMOTIONAL DISORDER 4 0.0001
375 AFFECTIVE DISORDER 1 0.0001
376 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
377 PRODUCT DOSE OMISSION ISSUE 36 0.0001
378 HYPERAESTHESIA 1 0.0001
379 DRUG INEFFECTIVE 157 0.0001
380 DEPRESSION 27 0.0001
381 INADEQUATE ANALGESIA 1 0.0001
382 RASH 51 0.0001
383 THERAPY CESSATION 6 0.0001
384 SKIN HYPERPIGMENTATION 1 0.0001
385 MUSCLE STRAIN 1 0.0001
386 SKIN SWELLING 1 0.0001
387 NERVOUSNESS 6 0.0001
388 LOCAL SWELLING 2 0.0001
389 BLOOD CALCIUM INCREASED 1 0.0001
390 SPINAL OSTEOARTHRITIS 1 0.0001
391 COLD SWEAT 2 0.0001
392 DRUG ERUPTION 2 0.0001
393 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
394 PAIN OF SKIN 3 0.0001
395 LOSS OF LIBIDO 1 0.0001
396 ANAL INCONTINENCE 1 0.0001
397 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
398 PELVIC PAIN 2 0.0001
399 BONE DISORDER 2 0.0001
400 PNEUMONIA BACTERIAL 1 0.0001
401 TINNITUS 5 0.0001
402 SKIN DISCOLOURATION 5 0.0001
403 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
404 PRODUCT DISTRIBUTION ISSUE 1 0.0001
405 EYE SWELLING 4 0.0001
406 THINKING ABNORMAL 2 0.0001
407 DIARRHOEA HAEMORRHAGIC 1 0.0001
408 ANXIETY 30 0.0001
409 DRUG PRESCRIBING ERROR 2 0.0001
410 DIZZINESS POSTURAL 1 0.0001
411 EAR PAIN 2 0.0001
412 DISABILITY 2 0.0001
413 HEART RATE INCREASED 10 0.0001
414 BLADDER DISORDER 1 0.0001
415 OVARIAN CYST 1 0.0001
416 DISCOMFORT 6 0.0001
417 DRUG ADMINISTRATION ERROR 3 0.0001
418 INITIAL INSOMNIA 1 0.0001
419 HEADACHE 61 0.0001
420 LIMB DISCOMFORT 3 0.0001
421 SKELETAL INJURY 1 0.0001
422 BREAST CANCER 9 0.0001
423 PRODUCT ODOUR ABNORMAL 1 0.0001
424 SKIN EXFOLIATION 8 0.0001
425 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
426 PALPITATIONS 11 0.0001
427 BREAST CANCER METASTATIC 1 0.0001
428 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
429 MENSTRUATION DELAYED 1 0.0001
430 PRODUCT STORAGE ERROR 8 0.0001
431 GASTROINTESTINAL PAIN 1 0.0001
432 VISUAL ACUITY REDUCED 3 0.0001
433 EXPIRED PRODUCT ADMINISTERED 3 0.0001
434 NERVE INJURY 1 0.0001
435 BLISTER 5 0.0001
436 SCAB 1 0.0001
437 MICTURITION URGENCY 1 0.0001
438 MUSCLE SPASMS 16 0.0001
439 SPINAL PAIN 1 0.0001
440 ERYTHEMA 17 0.0001
441 BURSITIS 1 0.0001
442 ADRENAL INSUFFICIENCY 1 0.0001
443 NOCTURIA 1 0.0001
444 VERTIGO 5 0.0001
445 RESTLESSNESS 3 0.0001
446 MUSCLE SPASTICITY 1 0.0001
447 CARDIOMEGALY 1 0.0001
448 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
449 PRURITUS 31 0.0001
450 DERMATITIS ALLERGIC 1 0.0001
451 ANOREXIA 1 0.0001
452 INJECTION SITE INDURATION 1 0.0001
453 RESPIRATORY TRACT INFECTION 2 0.0001
454 ANKYLOSING SPONDYLITIS 1 0.0001
455 HAIR TEXTURE ABNORMAL 1 0.0001
456 JOINT RANGE OF MOTION DECREASED 1 0.0001
457 DISTURBANCE IN ATTENTION 4 0.0001
458 PRODUCT TASTE ABNORMAL 1 0.0001
459 PERIPHERAL COLDNESS 1 0.0001
460 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
461 ORAL DISCOMFORT 1 0.0001
462 POLLAKIURIA 3 0.0001
463 HUNGER 1 0.0001
464 PAIN IN JAW 2 0.0001
465 MENTAL DISORDER 3 0.0001
466 INTENTIONAL PRODUCT MISUSE 6 0.0001
467 URINARY INCONTINENCE 2 0.0001
468 SKIN HAEMORRHAGE 1 0.0001
469 WEIGHT INCREASED 15 0.0001
470 HYPOAESTHESIA ORAL 1 0.0001
471 LACRIMATION INCREASED 2 0.0001
472 ACNE 5 0.0001
473 OSTEOPENIA 1 0.0001
474 DEVICE FAILURE 1 0.0001
475 EPILEPSY 2 0.0001
476 INSURANCE ISSUE 1 0.0001
477 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
478 THYROID DISORDER 1 0.0001
479 ANKLE FRACTURE 1 0.0001
480 TENDONITIS 1 0.0001
481 BACK PAIN 15 0.0001
482 BLOOD CHOLESTEROL INCREASED 3 0.0001
483 ARRHYTHMIA 3 0.0001
484 SCIATICA 1 0.0001
485 BACK DISORDER 1 0.0001
486 PRODUCT DOSE OMISSION 4 0.0001
487 CHOLELITHIASIS 2 0.0001
488 ABDOMINAL PAIN 14 0.0001
489 LIP SWELLING 2 0.0001
490 COAGULOPATHY 1 0.0001
491 DRY SKIN 8 0.0001
492 MALAISE 26 0.0001
493 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
494 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
495 INFLAMMATION 3 0.0001
496 NIGHTMARE 2 0.0001
497 DRUG WITHDRAWAL SYNDROME 5 0.0001
498 THIRST 1 0.0001
499 ADVERSE DRUG REACTION 5 0.0001
500 TOOTHACHE 1 0.0001
501 RESTLESS LEGS SYNDROME 1 0.0001
502 END STAGE RENAL DISEASE 1 0.0001
503 BLOOD GLUCOSE ABNORMAL 1 0.0001
504 CHEST PAIN 10 0.0001
505 HYPERSENSITIVITY 10 0.0001
506 NECK PAIN 3 0.0001
507 UNEVALUABLE EVENT 4 0.0001
508 MUSCULOSKELETAL DISORDER 1 0.0001
509 PULMONARY FIBROSIS 1 0.0001
510 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
511 LOWER LIMB FRACTURE 1 0.0001
512 GLAUCOMA 1 0.0001
513 DYSTONIA 1 0.0001
514 SURGERY 3 0.0001
515 KIDNEY INFECTION 1 0.0001
516 SPINAL FRACTURE 1 0.0000
517 INTENTIONAL SELF-INJURY 1 0.0000
518 PRODUCT ADMINISTRATION ERROR 1 0.0000
519 PSORIATIC ARTHROPATHY 2 0.0000
520 BODY TEMPERATURE INCREASED 1 0.0000
521 SINUSITIS 5 0.0000
522 OSTEOPOROSIS 2 0.0000
523 TOOTH LOSS 1 0.0000
524 URTICARIA 8 0.0000
525 KNEE ARTHROPLASTY 1 0.0000
526 IMPAIRED WORK ABILITY 1 0.0000
527 HYPOACUSIS 2 0.0000
528 SKIN CANCER 1 0.0000
529 RHINORRHOEA 3 0.0000
530 DEEP VEIN THROMBOSIS 3 0.0000
531 DEVICE LEAKAGE 2 0.0000
532 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
533 CHROMATURIA 1 0.0000
534 HEART RATE IRREGULAR 1 0.0000
535 DIZZINESS 22 0.0000
536 NEPHROLITHIASIS 2 0.0000
537 MUSCLE TWITCHING 1 0.0000
538 DEVICE MALFUNCTION 3 0.0000
539 PRODUCT PRESCRIBING ERROR 1 0.0000
540 THERAPY INTERRUPTED 3 0.0000
541 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
542 CONTUSION 4 0.0000
543 LOCALISED INFECTION 1 0.0000
544 FIBROMYALGIA 1 0.0000
545 NEURALGIA 1 0.0000
546 INJECTION SITE URTICARIA 1 0.0000
547 DYSGEUSIA 3 0.0000
548 VISUAL IMPAIRMENT 5 0.0000
549 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
550 CELLULITIS 2 0.0000
551 PRODUCT COMPLAINT 1 0.0000
552 FLUID RETENTION 2 0.0000
553 BLOOD PRESSURE INCREASED 6 0.0000
554 HYPOPHAGIA 1 0.0000
555 RASH GENERALISED 1 0.0000
556 SEDATION 1 0.0000
557 MUSCULOSKELETAL PAIN 2 0.0000
558 GASTRITIS 1 0.0000
559 HYPERTENSION 8 0.0000
560 EAR INFECTION 1 0.0000
561 BREAST CANCER FEMALE 1 0.0000
562 FEAR 1 0.0000
563 DRUG EFFECT DECREASED 2 0.0000
564 BLOOD BILIRUBIN INCREASED 1 0.0000
565 FREQUENT BOWEL MOVEMENTS 1 0.0000
566 DRY MOUTH 3 0.0000
567 NAUSEA 29 0.0000
568 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
569 ABNORMAL DREAMS 1 0.0000
570 ARTHRALGIA 15 0.0000
571 FEELING COLD 1 0.0000
572 WOUND 1 0.0000
573 ABDOMINAL DISCOMFORT 6 0.0000
574 OFF LABEL USE 31 0.0000
575 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
576 HYPERSOMNIA 1 0.0000
577 LIVER FUNCTION TEST ABNORMAL 1 0.0000
578 DYSSTASIA 1 0.0000
579 MUSCULOSKELETAL STIFFNESS 3 0.0000
580 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
581 ASCITES 1 0.0000
582 PAIN IN EXTREMITY 10 0.0000
583 APHASIA 1 0.0000
584 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
585 SWELLING 3 0.0000
586 BONE DENSITY DECREASED 1 0.0000
587 PULMONARY EMBOLISM 3 0.0000
588 HYPOTHYROIDISM 1 0.0000
589 PAIN 19 0.0000
590 DEVICE DIFFICULT TO USE 2 0.0000
591 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
592 BLOOD PRESSURE DECREASED 2 0.0000
593 VIRAL INFECTION 1 0.0000
594 DEHYDRATION 4 0.0000
595 URINARY RETENTION 1 0.0000
596 MYALGIA 5 0.0000
597 ABDOMINAL PAIN UPPER 6 0.0000
598 MEMORY IMPAIRMENT 4 0.0000
599 BURNING SENSATION 2 0.0000
600 INJURY 2 0.0000
601 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
602 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
603 AGITATION 2 0.0000
604 NASOPHARYNGITIS 5 0.0000
605 INJECTION SITE MASS 1 0.0000
606 FATIGUE 20 0.0000
607 PARAESTHESIA 4 0.0000
608 ABNORMAL BEHAVIOUR 1 0.0000
609 DISORIENTATION 1 0.0000
610 JOINT SWELLING 3 0.0000
611 OEDEMA PERIPHERAL 3 0.0000
612 INFLUENZA LIKE ILLNESS 2 0.0000
613 TREMOR 4 0.0000
614 ASTHENIA 9 0.0000
615 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
616 ROAD TRAFFIC ACCIDENT 1 0.0000
617 OSTEOARTHRITIS 1 0.0000
618 RECTAL HAEMORRHAGE 1 0.0000
619 BALANCE DISORDER 2 0.0000
620 SEPTIC SHOCK 1 0.0000
621 LIVER DISORDER 1 0.0000
622 DEVICE ISSUE 2 0.0000
623 VISION BLURRED 3 0.0000
624 SUICIDAL IDEATION 2 0.0000
625 WEIGHT DECREASED 6 0.0000
626 COUGH 6 0.0000
627 CARDIAC DISORDER 2 0.0000
628 DISEASE RECURRENCE 1 0.0000
629 MULTIPLE SCLEROSIS 1 0.0000
630 DRUG INTOLERANCE 2 0.0000
631 FLUSHING 2 0.0000
632 DYSPNOEA 11 0.0000
633 ILLNESS 2 0.0000
634 SPEECH DISORDER 1 0.0000
635 PANCREATITIS 1 0.0000
636 OEDEMA 1 0.0000
637 ARTHROPATHY 1 0.0000
638 CEREBROVASCULAR ACCIDENT 3 0.0000
639 FLATULENCE 1 0.0000
640 MUSCULAR WEAKNESS 2 0.0000
641 URINARY TRACT INFECTION 3 0.0000
642 LETHARGY 1 0.0000
643 EYE IRRITATION 1 0.0000
644 COVID-19 3 0.0000
645 DYSPHONIA 1 0.0000
646 BONE PAIN 1 0.0000
647 CHILLS 2 0.0000
648 DIARRHOEA 11 0.0000
649 VOMITING 8 0.0000
650 GAIT DISTURBANCE 3 0.0000
651 LOSS OF CONSCIOUSNESS 2 0.0000
652 SWELLING FACE 1 0.0000
653 PSORIASIS 2 0.0000
654 INJECTION SITE PRURITUS 1 0.0000
655 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
656 INJECTION SITE REACTION 1 0.0000
657 SKIN BURNING SENSATION 1 0.0000
658 BRONCHITIS 1 0.0000
659 HYPOAESTHESIA 2 0.0000
660 CHRONIC KIDNEY DISEASE 1 0.0000
661 INJECTION SITE SWELLING 1 0.0000
662 PERIPHERAL SWELLING 2 0.0000
663 ARTHRITIS 1 0.0000
664 INJECTION SITE BRUISING 1 0.0000
665 THROMBOSIS 1 0.0000
666 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
667 CONFUSIONAL STATE 2 0.0000
668 CARDIAC ARREST 1 0.0000
669 TREATMENT FAILURE 1 0.0000
670 DRUG ABUSE 1 0.0000
671 TACHYCARDIA 1 0.0000
672 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
673 OROPHARYNGEAL PAIN 1 0.0000
674 ANAEMIA 2 0.0000
675 DYSPEPSIA 1 0.0000
676 HYPOTENSION 2 0.0000
677 SOMNOLENCE 2 0.0000
678 CONDITION AGGRAVATED 3 0.0000
679 CHEST DISCOMFORT 1 0.0000
680 HAEMORRHAGE 1 0.0000
681 PNEUMONIA 3 0.0000
682 CONSTIPATION 2 0.0000
683 FALL 3 0.0000
684 INFLUENZA 1 0.0000
685 PYREXIA 3 0.0000
686 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
687 EMOTIONAL DISTRESS 1 0.0000
688 INJECTION SITE ERYTHEMA 1 0.0000
689 INFECTION 1 0.0000
690 INJECTION SITE PAIN 2 0.0000
691 DRUG DEPENDENCE 1 0.0000
692 OVERDOSE 1 0.0000
693 DECREASED APPETITE 1 0.0000
694 DEATH 1 0.0000